Derniers articles

Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France.

Abstract ObjectivesThis study aimed to fill the data gap regarding the prevalence of germline...

Posté par : Dr. Sophie PAGET-BAILLY, Mme. Aurélia MEURISSE
Nom de la revue : Cancers

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.

Abstract Cisplatin-based concurrent chemoradiation (CRT) remains the standard treatment for locally advanced head...

Posté par : Mr. Cyril BOISSON, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Oncoimmunology

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Abstract Patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors or antiangiogenic...

Posté par : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Nature Medicine

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors

AbstractContext and aimsEverolimus was approved in 2012 for the treatment of advanced hormone-receptor-positive,...

Posté par : Mr. Cyril BOISSON, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Breast Cancer Research

Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial

SummaryBackgroundThe standard of care for patients with locally advanced squamous cell anal carcinoma (SCAC) is...

Posté par : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Nom de la revue : Lancet Oncology

Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study

AbstractBackground: In RAS wild-type (WT) metastatic colorectal cancer (mCRC), preliminary data have suggested that...

Posté par : Mme. Aurélia MEURISSE
Nom de la revue : Journal of the National Cancer Institute

Cost-minimization analysis of the GORTEC 2014-04 randomized phase II study of stereotactic ablative radiotherapy (SABR) or chemotherapy-SABR in oligometastatic head and neck cancer

AbstractPurposeThe randomized phase II GORTEC 2014–04 and French Head and Neck Intergroup study showed deeper...

Posté par : Mr. Antoine FALCOZ, Mme. Aurélia MEURISSE
Nom de la revue : Radiotherapy and Oncology

Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations

AbstractPurpose: To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been...

Posté par : Mme. Aurélia MEURISSE
Nom de la revue : Support Care Cancer

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study

AbstractBackground: The modified docetaxel, cisplatin, and fluorouracil (mDCF) regimen has shown efficacy and...

Posté par : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Lancet Oncol.

French healthcare students and antibiotics: are they ready to promote their appropriate use?

AbstractObjectives: French healthcare students are required to carry out primary prevention interventions as part...

Posté par : Mme. Aurélia MEURISSE
Nom de la revue : JAC Antimicrob Resist

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients

AbstractObjectives: To assess health-related quality of life (QoL) in caregivers of elderly patients with chronic...

Posté par : Mme. Aurélia MEURISSE
Nom de la revue : Int J Public Health

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82)

AbstractBackground: Several cancer immunotherapies that target the PD-L1/PD-1 pathway show promising clinical...

Posté par : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : BMC Cancer

Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study

AbstractPurpose: Baseline circulating tumour DNA (ctDNA) is a potential prognostic marker in metastatic colorectal...

Posté par : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Eur J Cancer

Prevalence and Characteristics of Sleep Apnea in Intensive Care Unit Survivors After SARS-CoV-2 Pneumonia

AbstractBackground: Sleep apnea (SA) was reported as possibly exacerbating symptoms of COVID-19, a disease induced...

Posté par : Mme. Aurélia MEURISSE, Dr. Sophie PAGET-BAILLY
Nom de la revue : Nature and Science of Sleep

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial

AbstractSquamous Cell Carcinoma of the Anal canal (SCCA) is a rare disease associated with a Human Papillomavirus (HPV)...

Posté par : Mme. Aurélia MEURISSE
Nom de la revue : Front Oncol

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study

AbstractPurpose: Universal cancer peptide-based vaccine (UCPVax) is a therapeutic vaccine composed of two highly...

Posté par : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Nom de la revue : J Clin Oncol

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T H 1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

AbstractBackground: There is a strong rational of using anti-programmed cell death protein-1 and its ligand...

Posté par : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Nom de la revue : Front Oncol

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study

AbstractBackground: Red blood cell (RBC) transfusions are frequently required in the early period after kidney...

Posté par : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Nom de la revue : Frontiers in oncology

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

AbstractBackground: There is a paucity of data regarding the prognostic influence of peripheral blood CD4+ T...

Posté par : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Nom de la revue : BMC cancer

Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

AbstractIntroduction: Survivors of viral ARDS are at risk of long-term physical, functional and neuropsychological...

Posté par : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY
Nom de la revue : Annals of Intensive Care